- How, when, and why to evaluate the therapeutic response to checkpoint inhibitor immunotherapy in treating advanced non-small cell lung carcinoma2019 | First Faculty of Medicine
- Pseudoprogrese imitující kostní metastázu u pacienta léčeného nivolumabem pro metastazující melanom2019 | First Faculty of Medicine
- Comparison of RECIST 1.1 and iRECIST for response evaluation in solid tumours2017 | First Faculty of Medicine, Third Faculty of Medicine